Table 1.
Baseline demographics and clinical characteristics
| Characteristic | Lung infection (n = 36) | Extrapulmonary infection (n = 16) | Total (n = 52) |
|---|---|---|---|
| Age (years), mean ± SD (range) | 35.2 ± 22.2 (12.0–81.0) | 44.4 ± 18.3 (13.0–75.0) | 38.0 ± 21.3 (12.0–81.0) |
| Sex, n (%) | |||
| female | 29 (80.6) | 10 (62.5) | 39 (75.0) |
| male | 7 (19.4) | 6 (37.5) | 13 (25.0) |
| Diagnosis of cystic fibrosis, n (%) | 21 (58.3) | 1 (6.3) | 22 (42.3) |
| Country, n (%) | |||
| USA | 24 (66.7) | 11 (68.8) | 35 (67.3) |
| other | 12 (33.3) | 5 (31.2) | 17 (32.7)a |
| Organism, n (%) | |||
| M. abscessus complex | 30 (83.3) | 8 (50.0) | 38 (73.1) |
| M. chelonae | 2 (5.6) | 7 (43.8) | 9 (17.3) |
| M. abscessus/M. chelonae | 4 (11.1) | 1 (6.3) | 5 (9.6) |
aUK (n = 5), Israel (n = 4), Canada (n = 2), France (n = 2), Hong Kong (n = 2), Denmark (n = 1), Greece (n = 1).